Onxeo S.A.: Onxeo Changes Its Name and Becomes Valerio Therapeutics Following Approval by the Annual General Meeting of June 6, 2023

All the resolutions approved by the Board of Directors were adopted Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), ("Onxeo" or "the Company"), a clinical-stage biotechnology company

Related Keywords

Zeiten ,Mecklenburg Vorpommern ,Germany ,Paris ,France General ,France ,Shefali Agarwal ,Onxeo Sa Euronext ,Nicolas Trebouta ,Arthur Rouill ,Robert Coleman ,Nicolas Fossiez ,Stefan Klotter ,Company Group ,Euronext Growth Paris ,Annual General Meeting ,Valerio Therapeutic ,Chief Executive Officer ,General Meeting ,General Meetings ,Stabile Ertr ,Chart Profi Stefan Klotter ,Blue Chips ,Onxeo ,Changes ,Name ,Ecomes ,Valerio ,Herapeutics ,Following ,Approval ,Nnual ,Eneral ,Meeting ,Pune ,023 ,